Company Filing History:
5 out of 205 
4 out of 1,744 
2 out of 2 Years Active: 2018-2025
Title: Innovations of Jean-Michel Revest
Introduction
Jean-Michel Revest is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of cannabinoid-related disorders through his innovative research and patents. With a total of five patents to his name, Revest's work focuses on the development of specific pregnenolone derivatives for therapeutic applications.
Latest Patents
One of his latest patents is for the compound 3β-(4-methoxybenzyloxy)pregn-5-en-20-one, which is designed for use in the treatment of cannabinoids-related disorders. This invention relates to a specific pregnenolone derivative that has shown potent effects in inhibiting the impact of THC. The compound is effective in both unconditioned and conditioned effects of THC, including THC self-administration and reinstatement in THC-seeking behavior in non-human primates.
Career Highlights
Throughout his career, Jean-Michel Revest has worked with esteemed institutions such as Université de Bordeaux and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing the understanding of cannabinoid-related disorders and their treatment options.
Collaborations
Revest has collaborated with notable colleagues, including Pier Vincenzo Piazza and Monique Vallee, contributing to a rich exchange of ideas and research in his field.
Conclusion
Jean-Michel Revest's innovative work in the treatment of cannabinoid-related disorders highlights his significant contributions to medical research. His patents reflect a commitment to advancing therapeutic options for patients affected by these conditions.